Hepatitis A Nosode, Hepatitis B Nosode, Hepatitis C Nosode
Generic Name: hepatitis a nosode, hepatitis b nosode, hepatitis c nosode
Dosage form: LIQUID. Active ingredients: HEPATITIS A VIRUS (17 [hp_C]/mL); HEPATITIS B VIRUS (17 [hp_C]/mL); HEPATITIS C VIRUS (17 [hp_C]/mL). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: LIQUID. Active ingredients: HEPATITIS A VIRUS (17 [hp_C]/mL); HEPATITIS B VIRUS (17 [hp_C]/mL); HEPATITIS C VIRUS (17 [hp_C]/mL). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as liquid.
Related Medications
Guaifenesin Tablets 400
guaifenesin tablets 400
Expectorant [EPC]
cough, cold
Heparin Sodium
heparin sodium
11 DESCRIPTION Heparin is a heterogeneous group of straight-chain anionic mucopolysaccharides, called glycosaminoglycans, having anticoagulant properties. Although others may be present, the main sugars occurring in heparin are: (1) α -L-iduronic acid 2-sulfate, (2) 2-deoxy-2-sulfamino- α -D-glucose 6-sulfate, (3) β -D-glucuronic acid, (4) 2-acetamido-2-deoxy- α -D-glucose and (5) α -L-iduronic acid.
Elagolix
elagolix
11 DESCRIPTION ORILISSA (elagolix) tablets for oral administration contain elagolix sodium, the sodium salt of the active moiety elagolix. Elagolix sodium is a nonpeptide small molecule, GnRH receptor antagonist. Elagolix sodium is chemically described as sodium 4-({(1 R )-2-[5-(2-fluoro-3-methoxyphenyl)-3-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-4-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2 H )-yl]-1-phenylethyl}amino)butanoate.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.